Abstract
A critical problem in the development and implementation of stem cell-based therapy is the lack of reliable, noninvasive means to image and trace the cells post-transplantation and evaluate their biodistribution, final fate, and functionality. In this study, we developed a gold nanoparticle-based CT imaging technique for longitudinal mesenchymal stem cell (MSC) tracking within the brain. We applied this technique for noninvasive monitoring of MSCs transplanted in a rat model for depression. Our research reveals that cell therapy is a potential approach for treating neuropsychiatric disorders. Our results, which demonstrate that cell migration could be detected as early as 24 h and up to one month post-transplantation, revealed that MSCs specifically navigated and homed to distinct depression-related brain regions. We further developed a noninvasive quantitative CT ruler, which can be used to determine the number of cells residing in a specific brain region, without tissue destruction or animal scarification. This technique may have a transformative effect on cellular therapy, both for basic research and clinical applications. (Figure Presented).
| Original language | English |
|---|---|
| Pages (from-to) | 9274-9285 |
| Number of pages | 12 |
| Journal | ACS Nano |
| Volume | 8 |
| Issue number | 9 |
| DOIs | |
| State | Published - 23 Sep 2014 |
Bibliographical note
Publisher Copyright:© 2014 American Chemical Society.
Keywords
- CT
- Mesenchymal stem cells (MSCs)
- cell tracking
- depression disorders
- gold nanoparticles